Onesource Specialty Pharma Limited has submitted the Exchange voting results along with a copy Srutinizers report of Postal Ballot process held on July 30, 2025
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
OneSource Specialty Pharma Limited has submitted the results of its postal ballot (e-voting held from July 1 to July 30, 2025) for two special resolutions, both of which were passed. The first resolution approved the appointment of Mr. Colin Michael Bond as an Independent Director for a five-year term, with 99.96% of votes in favor (7.31 crore shares out of 7.32 crore polled; 63.91% shareholder participation). The second resolution approved a revision in the remuneration of Managing Director Mr. Neeraj Sharma, passing with 82.93% in favor (6.07 crore shares in favor versus 1.25 crore against, out of 7.31 crore polled). Voter turnout was around 63.9% among the 90,407 shareholders on record date June 27, 2025. While promoters and retail investors voted overwhelmingly in favor of the MD pay revision, public institutional investors showed notable dissent, with 38% voting against (1.25 crore shares).
Both resolutions are deemed effective from July 30, 2025, meaning the new Independent Director is appointed and the MD's revised pay takes effect. The substantial institutional pushback (38% dissent) on the MD remuneration, while not enough to block the resolution, signals some investor concern on executive pay and may be worth monitoring as a governance indicator.